von Tobias Borgers | Nov. 23, 2019 | Roche
Media Release Basel, 16 September 2019 Roche ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Indices for the eleventh year running Roche ranked second in the 2019 Dow Jones Sustainability Indices The ranking acknowledges...
von Tobias Borgers | Nov. 7, 2019 | Roche
Media Release Basel, 06 November 2019 Roche to present new data highlighting breadth of haematology portfolio and pipeline at the American Society of Hematology 2019 Annual Meeting Ten Roche medicines will be featured in more than 70 abstracts and 21 oral...
von Tobias Borgers | Okt. 31, 2019 | Roche
Media Release Basel, 06 February 2019 Roche joins the World Federation of Hemophilia Humanitarian Aid Program Hemlibra donation will provide prophylactic treatment to as many as 1,000 people with haemophilia A over five years in countries where there is little or no...
von Tobias Borgers | Okt. 27, 2019 | Roche
Media Release Basel, 05 March 2019 Roche Annual General Meeting 2019 All proposals of the Board of Directors approved Christoph Franz as Chairman of the Roche Board of Directors and all other Board members standing for re-election approved; Professor Dr Hans Clevers...
von Tobias Borgers | Okt. 11, 2019 | Roche
Media Release Basel, 25 July 2019 Roche reports very strong performance in the first half of 2019 – Outlook raised Group sales increase 9%1 at constant exchange rates and 8% in Swiss francs Pharmaceuticals Division sales up 10%, driven mainly by Ocrevus, Hemlibra,...
von Tobias Borgers | Okt. 9, 2019 | Roche
Media Release Basel, 10 September 2019 Roche presents new OCREVUS (ocrelizumab) biomarker data that increase understanding of disease progression in multiple sclerosis at ECTRIMS Blood neurofilament light chain (NfL) levels were significantly lowered following OCREVUS...
